Search Results for: ALBUMIN MARKET Global Human Albumin
Articles
June 2, 2015
PLASMA-DERIVED BIOLOGICS - New Fractionation Process to Expand Availability of Plasma-Derived Treatments June 2, 2015
Jeffrey B. Davis, MBA, explains how his company has initiated a three-phase process of scaling up the Salt Diafiltration Process, validating it for required FDA filings, and ultimately running the process at production scale to enable the clinical trial product to be produced.
May 20, 2015
Novozymes Biopharma Enables Stable Formulation of Serendex Pharmaceutical’s Drug May 20, 2015
Denmark-based Serendex Pharmaceuticals recently announced they will initiate Phase I clinical trials for their Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)...
March 24, 2015
Key TxCell Patent to be Granted for its Lead Product March 24, 2015
TxCell SA recently announced that a key patent is to be granted by the United States Patent and Trademark Office...
April 7, 2014
Novozymes’ VELTIS Technology Used in GlaxoSmithKline Drug Approved in Europe April 7, 2014
Novozymes Biopharma DK A/S recently announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the...
February 1, 2014
Novozymes Biopharma Announces New Data Highlighting Potential for Monthly Drug Dosing February 1, 2014
Novozymes Biopharma recently announced new data on extending the serum half-life of albumin in vivo. This compelling data set, recently...
October 25, 2013
Novozymes Biopharma Announces Major Collaboration With Almac October 25, 2013
Novozymes Biopharma recently announced its new collaboration with Almac to provide a combined service for drug development applications in the...
February 28, 2013
3/6/2013 February 28, 2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
January 14, 2013
1/16/2013 January 14, 2013
BIND Biosciences & Amgen Sign Worldwide Development & Commercialization Agreement BIND Biosciences recently announced it has entered into a global...
October 25, 2012
10/30/2012 October 25, 2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
April 18, 2012
4/25/2012 April 18, 2012
Alitair Announces Patent Allowance for Platform Delivery Technology Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates...
April 18, 2012
Baxter International's New Plant to Bring 1,500 High-Paying Jobs April 18, 2012
Baxter International Inc. recently announced it will build a new state-of-the-art manufacturing facility in Georgia to support growth of its...
December 18, 2011
12/20/2011 December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
September 27, 2011
Novozymes to Supply Recombumin for Type 2 Diabetes Drug September 27, 2011
Novozymes to Supply Recombumin for Type 2 Diabetes Drug Novozymes Biopharma, part of Novozymes A/S, recently announced it has concluded...
June 15, 2011
6/21/2011 June 15, 2011
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity Tekmira Pharmaceuticals Corporation recently provided comments...
May 19, 2011
5/24/2011 May 19, 2011
Sartorius Stedim Biotech & RAUMEDIC Sign Partnership Agreement Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and...
January 30, 2011
2/1/2011 January 30, 2011
Ligand Pharmaceuticals Forms Drug Development Alliance With Chiva PharmaceuticalsLigand Pharmaceuticals, Inc. recently announced it has entered into a strategic relationship...
January 30, 2011
Catalent Announces Partnership With Nuron Biotech January 30, 2011
Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies, and supply solutions, recently announced it...Issues
April 27, 2018
November / December 2012
COVER CONTRACT SERVICES – Industry Trends: Outsourcing Pharmaceutical Development & Innovation Frost & Sullivan Analysts Winny Tan, PhD, and Jennifer...
